2001-January Archives by Date
Starting: Tue Jan 2 10:06:04 2001
Ending: Wed Jan 31 13:21:07 2001
Messages: 71
- [Pharm-policy] Justin Gillis on Canavan gene patent
James Love
- [Pharm-policy] Washington Post editorial on US parallel import legislation
James Love
- [Pharm-policy] HHS Secretary Ashcroft "Ties to White Supremacists"
Paul Davis
- [Pharm-policy] Correction: Ashcroft for AG, _not_ HHS
Paul Davis
- [Pharm-policy] Bush Transition team members for DHHS
Mike Palmedo
- [Pharm-policy] India dispute over WTO EMR transition rules
James Love
- [Pharm-policy] Susan Finston of PhRMA on India EMR dispute
James Love
- [Pharm-policy] Glaxo among 10 Worst Corporations of 2000
Robert Weissman
- [Pharm-policy] Patent Office to Issue New Gene Guidelines
James Love
- [Pharm-policy] US PTO Utility Examination Guidelines
James Love
- [Pharm-policy] Rep Thomas/USTR/Accussations to foreigns
MFJorge@aol.com
- [Pharm-policy] Interview with WIPO's Kifle Shenkoru
love@cptech.org
- [Pharm-policy] Australia studies pharmaceutical prices
James Love
- [Pharm-policy] Bernie Sanders to WP on US reimportation bill
James Love
- [Pharm-policy] Don McNeil in NYT on Romania's AIDS Children
James Love
- [Pharm-policy] (no subject)
love@cptech.org
- [Pharm-policy] Access to fluconazole in less-developed countries
James Love
- [Pharm-policy] Re: CD 4 count information
James Love
- [Pharm-policy] CD 4 count information
stefan stojanovik
- [Pharm-policy] Canadian court ruling on trade dress
James Love
- [Pharm-policy] Re: CD 4 count information
stefan stojanovik
- [Pharm-policy] [Fwd: [Ip-health] Doctor who puts patient rights before patent rights]
Mike Palmedo
- [Pharm-policy] Re: CD 4 count information
Gonsalves, Gregg
- [Pharm-policy] Generic Claritin lawsuit
Mike Palmedo
- [Pharm-policy] URL for Canada trade dress case
James Love
- [Pharm-policy] Re: CD 4 count information
HERA
- [Pharm-policy] pharmaceutical multinationals are at it again in South Africa
Prof. Udo Schuklenk
- [Pharm-policy] [Fwd: [Ip-health] Lancet-Nigerian govt investiages Pfizer drug trial
allegatio]
Mike Palmedo
- [Pharm-policy] Washington Post on Pfizer's Nigerian drug trials
Mike Palmedo
- [Pharm-policy] NY Times on Bayer-CuraGen agreement
Mike Palmedo
- [Pharm-policy] South Africa fights Aids drug apartheid
Mike Palmedo
- [Pharm-policy] Drug company funding of patient groups in Australia
love@cptech.org
- [Pharm-policy] USTR Announces Draft FTAA Text, Releases Summaries of U.S. Positions
Robert Weissman
- [Pharm-policy] Summary of US IP position for FTAA (fwd)
Robert Weissman
- [Pharm-policy] The Big Drug Run To The Border
Dean Hughson
- [Pharm-policy] The Big Drug Run To The Border
James Love
- [Pharm-policy] Davis and Arno: Why Don't We Enforce Existing Drug Price Controls?
James Love
- [Pharm-policy] looking for data on IPR litigation costs
James Love
- [Pharm-policy] Antitrust Issues in Settlement of Pharmaceutical Patent Disputes
James Love
- [Pharm-policy] News from Bangkok
Alacran7@aol.com
- [Pharm-policy] Query on UN General Assemblyu
P. Davis
- [Pharm-policy] Audit finds Medicare paid twice as much as veterans for same drugs
James Love
- [Pharm-policy] Recommended state practice for compulsory licensing
James Love
- [Pharm-policy] Bush considers reversing Africa Executive Order
James Love
- [Pharm-policy] Section 15c of the South Africa Medicines Act
James Love
- [Pharm-policy] UK: Bayer in Illegal Drug Trial
Mike Palmedo
- [Pharm-policy] London Sunday Times on Bayer drug trials
Mike Palmedo
- [Pharm-policy] Counterfeiting problems in China
James Love
- [Pharm-policy] a better (private) Medicare prescription benefit plan
pill@shorenetworks.com
- [Pharm-policy] a better (private) prescription for Medicare
pill@shorenetworks.com
- [Pharm-policy] Text of the Africa/HIV/AIDS executive order 13155
James Love
- [Pharm-policy] Re:Ideas on Access to Drugs Issues
Paul Davis
- [Pharm-policy] Glaxo plan to block generic Paxil, US Judge won't unseal documents
love@cptech.org
- [Pharm-policy] Susan Finston: More on India and the EMR Application Process
James Love
- [Pharm-policy] HIV testing patents
love@cptech.org
- [Pharm-policy] Glaxo closes SA drug factor, TAC says nationalize and produce generics
love@cptech.org
- [Pharm-policy] Tina Rosenberg's NYT Magazine article on HIV/AIDS crisis
love@cptech.org
- [Pharm-policy] Essential Action/CPTech Comments on US-Chile FTA
Robert Weissman
- [Pharm-policy] CIPLA requests licenses from Glaxo, Pfizer, BMS, and BI
love@cptech.org
- [Pharm-policy] [Toronto Globel and Mail] J'accuse!
Gordon Irlam
- [Pharm-policy] Nairobi press on South Africa lawsuit over medicines act
love@cptech.org
- [Pharm-policy] Merck collaboration with rivals
love@cptech.org
- [Pharm-policy] Re: [Ip-health] Re:Ideas on Access to Drugs Issues
Professor Olive Shisana
- [Pharm-policy] RE: [Ip-health] Susan Finston: More on India and the EMR Applicat
ion Process
Dehoney, Eleanor
- [Pharm-policy] Re: [Ip-health] HIV testing patents
Gregg Gonsalves
- [Pharm-policy] [Toronto] Globe & Mail editorial - Jan 29, 2001
Richard Elliott
- [Pharm-policy] Uganda: Glaxo's letter to Cipla regarding sales of AZT and 3TC
James Love
- [Pharm-policy] CSU v. Xerox brief
James Love
- [Pharm-policy] Zoellick comments in Senate re Africa Exec Order
James Love
- [Pharm-policy] India: Pharma industry demands tax exemption during R&D operations
love@cptech.org
- [Pharm-policy] USTR out-of-cycle reviews
Mike Palmedo
Last message date:
Wed Jan 31 13:21:07 2001
Archived on: Wed Jan 31 13:21:07 2001
This archive was generated by
Pipermail 0.05 (Mailman edition).